These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28766270)

  • 1. Oxytocin and Autism Spectrum Disorders.
    Yamasue H; Domes G
    Curr Top Behav Neurosci; 2018; 35():449-465. PubMed ID: 28766270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders.
    Yamasue H
    Psychiatry Clin Neurosci; 2016 Feb; 70(2):89-99. PubMed ID: 26394796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oxytocin administration on individuals with ASD: Neuroimaging and behavioral evidence.
    Baker E; Stavropoulos KKM
    Prog Mol Biol Transl Sci; 2020; 173():209-238. PubMed ID: 32711811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
    Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
    Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin and Animal Models for Autism Spectrum Disorder.
    Wagner S; Harony-Nicolas H
    Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Possible Role of Oxytocin in Autism Spectrum Disorder].
    Munesue T; Minabe Y
    Seishin Shinkeigaku Zasshi; 2016; 118(6):399-409. PubMed ID: 30620499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ooi YP; Weng SJ; Kossowsky J; Gerger H; Sung M
    Pharmacopsychiatry; 2017 Jan; 50(1):5-13. PubMed ID: 27574858
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
    Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
    Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances in the management of autism spectrum disorders in children].
    Li HH; Shan L; Du L; Jia FY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):886-92. PubMed ID: 26287360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Novel Therapeutics for Core Symptoms of Autism Spectrum Disorder: An Integrative Approach of Clinical Trials, Neuroimaging, and Genomics].
    Yamasue H
    Brain Nerve; 2019 Sep; 71(9):971-980. PubMed ID: 31506399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of oxytocin in autism: Current status of the research].
    Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R
    Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B).
    Spanos M; Chandrasekhar T; Kim SJ; Hamer RM; King BH; McDougle CJ; Sanders KB; Gregory SG; Kolevzon A; Veenstra-VanderWeele J; Sikich L
    Contemp Clin Trials; 2020 Nov; 98():106103. PubMed ID: 32777383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical potential of oxytocin in autism spectrum disorder: current issues and future perspectives.
    Benner S; Yamasue H
    Behav Pharmacol; 2018 Feb; 29(1):1-12. PubMed ID: 28857771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.
    Alvares GA; Quintana DS; Whitehouse AJ
    Autism Res; 2017 Jan; 10(1):25-41. PubMed ID: 27651096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring effects of oxytocin on the attentional preference for faces in autism.
    Kanat M; Spenthof I; Riedel A; van Elst LT; Heinrichs M; Domes G
    Transl Psychiatry; 2017 Apr; 7(4):e1097. PubMed ID: 28418399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.
    Parker KJ; Oztan O; Libove RA; Sumiyoshi RD; Jackson LP; Karhson DS; Summers JE; Hinman KE; Motonaga KS; Phillips JM; Carson DS; Garner JP; Hardan AY
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):8119-8124. PubMed ID: 28696286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxytocin in the treatment of the social deficits associated to autism spectrum disorders].
    Cachafeiro-Espino C; Vale-Martínez AM
    Rev Neurol; 2015 Nov; 61(9):421-8. PubMed ID: 26503318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
    Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
    Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.